XML 54 R46.htm IDEA: XBRL DOCUMENT v3.24.0.1
Grant Revenue - Additional Information (Details) - USD ($)
 3 Months Ended 12 Months Ended
Sep. 19, 2022
Mar. 31, 2023
Dec. 31, 2022
Dec. 31, 2023
Dec. 31, 2022
Grant [Member]          
Disaggregation of Revenue [Line Items]          
Revenue recognized       $ 4,913,000 $ 224,000
CPRIT Contract [Member]          
Disaggregation of Revenue [Line Items]          
Maximum grant amount to be received as per grant contract $ 17,600,000        
Grant funding term 3 years        
CPRIT grant funding term, description       The CPRIT Grant is subject to customary CPRIT funding conditions, including, but not limited to, a matching fund requirement (one dollar for every two dollars awarded by CPRIT), revenue sharing obligations upon commercialization of rhenium (186Re) obisbemeda based on specific dollar thresholds and tiered low single digit royalty rates until CPRIT receives the aggregate amount of 400% of the proceeds awarded under the CPRIT Grant, and certain reporting requirements.  
Contract effective date Aug. 31, 2022        
Contract termination date Aug. 30, 2025        
Percentage of aggregate amount of proceeds awarded under CPRIT grant 400.00%        
Percentage of grant proceeds with interest not exceed annually 5.00%        
Identified eligible reimbursable costs   $ 168,000 $ 637,000    
Increase in grant revenue       $ 637,000  
CPRIT Contract [Member] | Grant [Member]          
Disaggregation of Revenue [Line Items]          
Revenue recognized       $ 4,900,000 $ 200,000